AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
CRBP Corbus Pharmaceuticals
- 5.7500
- -0.2500-4.17%
Close Mar 21 16:00 ET
- 5.9000
- +0.1500+2.61%
Post 19:22 ET
70.34MMarket Cap-1.56P/E (TTM)
5.9325High5.6500Low428.33KVolume5.9100Open6.0000Pre Close2.47MTurnover5.71%Turnover RatioLossP/E (Static)12.23MShares61.900052wk High0.49P/B43.14MFloat Cap5.650052wk Low--Dividend TTM7.50MShs Float323.4000Historical High--Div YieldTTM4.71%Amplitude2.1100Historical Low5.7760Avg Price1Lot Size
Corbus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -15.77%-41.79M | -82.12%-10.94M | -94.29%-13.94M | -14.63%-8.94M | 47.29%-7.97M | 3.85%-36.1M | 19.41%-6.01M | 0.95%-7.18M | 36.21%-7.8M | -42.39%-15.11M |
| Net income from continuing operations | 9.85%-40.21M | -18.80%-9.53M | -37.10%-13.78M | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.26%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M |
| Operating gains losses | ---- | ---- | ---- | ---- | 572.86%6.41K | ---- | ---- | ---- | ---- | -100.38%-1.36K |
| Depreciation and amortization | -8.27%588K | -9.46%134K | -0.65%152K | -4.94%150.31K | -16.60%151.69K | -15.99%641K | -19.74%148K | -19.81%153K | -17.68%158.13K | -7.08%181.87K |
| Other non cash items | -27.33%585K | 25.95%199K | -51.14%107K | -59.74%91.33K | -6.69%187.67K | 8.42%805K | -22.02%158K | 20.06%219K | 25.65%226.88K | 13.69%201.12K |
| Change In working capital | -236.20%-5.58M | -357.84%-2.55M | -210.76%-2.03M | 426.51%488.89K | -204.44%-1.49M | 224.11%4.09M | -54.06%989K | 17,075.71%1.83M | 89.93%-149.73K | 136.00%1.42M |
| -Change in prepaid assets | 16.39%-1.23M | -2,435.48%-2.36M | 22.71%-524K | 407.74%424.01K | 318.99%1.23M | -193.43%-1.47M | -169.12%-93K | -183.08%-678K | -132.84%-137.78K | -376.26%-561.22K |
| -Change in payables and accrued expense | -166.15%-4.01M | -103.27%-65K | -131.82%-1.37M | 44.04%194.46K | -629.13%-2.76M | 239.26%6.06M | -7.49%1.99M | 723.08%4.32M | 107.62%135.01K | 90.60%-379.01K |
| -Change in other current assets | 49.48%1.14M | 19.61%244K | 7.31%235K | 32.59%228.47K | 157.59%434.54K | 24.05%764K | 21.77%204K | 41.19%219K | 15.33%172.31K | 17.28%168.69K |
| -Change in other current liabilities | -17.63%-1.48M | 66.49%-371K | 82.00%-365K | -12.15%-358.04K | -117.63%-386.96K | -10.74%-1.26M | -275.48%-1.11M | -601.73%-2.03M | -12.69%-319.26K | 913.58%2.2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -15.77%-41.79M | -82.12%-10.94M | -94.29%-13.94M | -14.63%-8.94M | 47.29%-7.97M | 3.85%-36.1M | 19.41%-6.01M | 0.95%-7.18M | 36.21%-7.8M | -42.39%-15.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -440.36%-121.31M | -15.96%8.73M | -241.00%-15.37M | -286.66%-16.44M | -1,870.11%-98.24M | 18.51%35.64M | -11.81%10.39M | 282.49%10.9M | 147.11%8.81M | -87.08%5.55M |
| Net investment purchase and sale | -440.36%-121.31M | -15.96%8.73M | -241.00%-15.37M | -286.66%-16.44M | -1,870.11%-98.24M | 18.49%35.64M | -11.81%10.39M | 282.49%10.9M | 147.09%8.81M | -87.09%5.55M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -440.36%-121.31M | -15.96%8.73M | -241.00%-15.37M | -286.66%-16.44M | -1,870.11%-98.24M | 18.51%35.64M | -11.81%10.39M | 282.49%10.9M | 147.11%8.81M | -87.08%5.55M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 6,004.93%166.58M | 99.32%-13K | 3,150.43%25.04M | 194,039.19%34.96M | 94,412.48%106.58M | -428.66%-2.82M | -912.98%-1.91M | -641.62%-821K | 105.46%18.01K | 65.45%-113.01K |
| Net issuance payments of debt | -438.62%-15.48M | --0 | -1,370.58%-10.9M | -1,391.56%-2.27M | -1,443.86%-2.32M | -438.59%-2.87M | -881.40%-1.83M | -569.35%-741K | 53.97%-151.93K | 54.13%-150.07K |
| Net common stock issuance | 343,405.66%182.06M | 82.43%-13K | 45,026.25%35.94M | 17,870.63%30.54M | 311,833.25%115.59M | --53K | ---74K | ---80K | --169.94K | --37.06K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---6.69M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 6,004.93%166.58M | 99.32%-13K | 3,150.43%25.04M | 194,039.19%34.96M | 94,412.48%106.58M | -428.66%-2.82M | -912.98%-1.91M | -641.62%-821K | 105.46%18.01K | 65.45%-113.01K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.55%14.39M | 68.58%20.09M | 170.05%24.36M | 84.79%14.77M | -18.55%14.39M | -31.17%17.67M | -9.11%11.92M | -65.89%9.02M | -86.14%7.99M | -31.17%17.67M |
| Current changes in cash | 205.95%3.47M | -189.90%-2.23M | -247.00%-4.26M | 835.54%9.58M | 103.92%379.44K | 59.03%-3.28M | -45.71%2.48M | 121.76%2.9M | 103.28%1.02M | -130.23%-9.68M |
| End cash Position | 24.14%17.87M | 24.14%17.87M | 68.58%20.09M | 170.05%24.36M | 84.79%14.77M | -18.55%14.39M | -18.55%14.39M | -9.11%11.92M | -65.89%9.02M | -86.14%7.99M |
| Free cash flow | -15.77%-41.79M | -82.12%-10.94M | -94.29%-13.94M | -14.63%-8.94M | 47.29%-7.97M | 3.88%-36.1M | 19.41%-6.01M | 0.95%-7.18M | 36.21%-7.8M | -42.21%-15.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025